Table 1.
Gene null mutant | ORF namea | 96-well screening 4-MUC assay | Condensed sample 4-MUC assay (o/n OD600) |
---|---|---|---|
Protein-trafficking genes: | |||
chc1∆::KanMX |
YGL206C |
2.5 |
2.4 (2.8) |
clc1∆::KanMX |
YGR167W |
3.8 |
2.6 (3.1) |
nyv1∆::KanMX |
YLR093Cf |
1.5 |
1.7 (5.7) |
pep12∆::KanMX |
YOR036W |
1.9 |
2.6 (2.9) |
vam3∆::KanMX |
YOR106W |
1.6 |
NA |
vps1∆::KanMX |
YKR001C |
1.2 |
NA |
vps15∆::KanMX |
YBR097W |
1.9 |
1.3 (4.2) |
vps21∆::KanMX |
YOR089Cf |
3.3 |
6.5 (6.1) |
vps33∆::KanMX |
YLR396C |
1.5 |
0.9 (5.5) |
ypt7∆::KanMX |
YML001Wb |
1.7 |
1.0 (5.1) |
Glycosylation-related genes: | |||
aga2∆::KanMX |
YGL032C |
0.9 |
NA |
alg3∆::KanMX |
YBL082Cc |
0.5 |
NA |
alg5∆::KanMX |
YPL227Cc |
0.7 |
NA |
alg6∆::KanMX |
YOR002Wc |
0.8 |
NA |
alg8∆::KanMX |
YOR067Cc |
1.5 |
NA |
alg9∆::KanMX |
YNL219Cc |
1.5 |
NA |
alg12∆::KanMX |
YNR030Wc |
1.7 |
NA |
anp1∆::KanMX |
YEL036Cc |
1.8 |
NA |
csg2∆::KanMX |
YBR036C |
1.0 |
NA |
cwh41∆::KanMX |
YGL027Cc |
0.1 |
NA |
cwh43∆::KanMX |
YCR017C |
1.3 |
NA |
die2∆::KanMX |
YGR227Wc |
1.5 |
NA |
gda1∆::KanMX |
YEL042W |
1.6 |
NA |
gnt1∆::KanMX |
YOR320C |
1.2 |
NA |
gon7∆::KanMX |
YJL184W |
0.1 |
NA |
gtb1∆::KanMX |
YDR221Wd,e |
2.7 |
0.0 (12.6) |
hoc1∆::KanMX |
YJR075W |
0.9 |
NA |
hor7∆::KanMX |
YMR251W-A |
1.4 |
NA |
ktr1∆::KanMX |
YOR099Wd |
0.8 |
NA |
ktr2∆::KanMX |
YKR061Wd,f |
0.9 |
NA |
ktr3∆::KanMX |
YBR205Wd |
1.0 |
NA |
ktr4∆::KanMX |
YBR199Wd |
1.0 |
NA |
ktr5∆::KanMX |
YNL029Cc |
1.0 |
NA |
ktr6∆::KanMX |
YPL053Cd |
1.3 |
NA |
ktr7∆::KanMX |
YIL085Cd |
1.0 |
NA |
mnl1∆::KanMX |
YHR204Wd |
1.2 |
NA |
mnn2∆::KanMX |
YBR015Cc |
1.3 |
0.8 (3.8) |
mnn5∆::KanMX |
YJL186Wf |
1.9 |
3.0 (5.6) |
mnn9∆::KanMX |
YPL050Cc,f |
2.2 |
3.8 (5.5) |
mnn10∆::KanMX |
YDR245W |
2.5 |
6.0 (3.8) |
mnn11∆::KanMX |
YJL183Wc |
2.0 |
4.5 (3.7) |
mns1∆::KanMX |
YJR131Wd |
0.5 |
NA |
mnt2∆::KanMX |
YGL257Cd |
1.2 |
NA |
mnt3∆::KanMX |
YIL014Wd,e |
2.5 |
1.7 (5.2) |
mrl1∆::KanMX |
YPR079Wf |
1.6 |
NA |
ost3∆::KanMX |
YOR085Wc |
1.1 |
NA |
ost4∆::KanMX |
YDL232Wc,f |
1.6 |
NA |
ost5∆::KanMX |
YGL226C-Ac |
0.9 |
NA |
ost6∆::KanMX |
YML019Wc,f |
1.8 |
NA |
pmt1∆::KanMX |
YDL095Wc |
3.1 |
3.2 (4.7) |
pmt2∆::KanMX |
YAL023Cc |
5.3 |
1.8 (4.7) |
pmt3∆::KanMX |
YOR321Wc |
1.1 |
1.0 (4.4) |
pmt5∆::KanMX |
YDL093Wc |
2.1 |
4.3 (6.3) |
pmt6∆::KanMX |
YGR199Wc |
0.8 |
NA |
ynd1∆::KanMX |
YER005Wf |
1.1 |
NA |
yur1∆::KanMX |
YJL139Cf |
2.0 |
2.8(4.5) |
yjr061w∆::KanMX | YJR061W | 1.0 | NA |
aYGL038C, YLR240W, YGL095C knockout strains failed to be transformed with PCX.
bEnhancement of Ctcel8A endocellulase activity [52].
Enhancementc and decreased of Cel8Aenz endocellulase activity [48].
eDetectable NpaBGS beta-glucosidase activity as screened by pNPG assay.
fThe null mutant could grow in SC-URA medium with 1% cellobiose when the NpaBGS beta-glucosidase gene is functional inside.
The 4-MUC activity ratio is the average PCX activity of the three highest expressing recombinants (single-gene-KO strain) to the average original PCX activity (BY4741 strain).